New Weight-Loss drug candidate enters early human testing
Symptom relief
Recruiting now
This early-stage study tests a new drug called ALV-100 in 180 adults who are overweight or obese, with or without type 2 diabetes. The main goal is to check the drug's safety and how the body processes it. Participants receive either the drug or a placebo, and researchers will mo…
Phase: PHASE1 • Sponsor: Alveus Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC